Significant Changes in Plasma Alpha-Synuclein and Beta-Synuclein Levels in Male Children with Autism Spectrum Disorder
Open Access
- 8 April 2018
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-7
Abstract
Alpha-synuclein (α-synuclein) and beta-synuclein (β-synuclein) are presynaptic proteins playing important roles in neuronal plasticity and synaptic vesicle regulation. To evaluate the association of these two proteins and autism spectrum disorder (ASD), we investigated the plasma α-synuclein and β-synuclein levels in 39 male children with ASD (2 subgroups: 25 autism and 14 pervasive developmental disorder-not otherwise specified (PDD-NOS)) comparing with 29 sex- and age-matched controls by using enzyme-linked immunosorbent assay (ELISA). We first determined the levels of these two proteins in the ASD subgroups and found that there were no significant differences in both plasma α-synuclein and β-synuclein levels in the autism and PDD-NOS groups. Thus, we could combine the 2 subgroups into one ASD group. Interestingly, the mean plasma α-synuclein level was significantly lower () in the ASD children ( ng/mL) than in the controls ( ng/mL), while the mean plasma β-synuclein level in the ASD children ( ng/mL) was significantly higher () than in the controls ( ng/mL). This is the first study examining the associations between α-synuclein and β-synuclein and male ASD patients. We found that alterations in the plasma α-synuclein and β-synuclein levels might be implicated in the association between synaptic abnormalities and ASD pathogenesis.
Keywords
Funding Information
- National Center for Genetic Engineering and Biotechnology (BT-B-01-MG-18-4814, 59-082-05-2)
- Prince of Songkla University (BT-B-01-MG-18-4814, 59-082-05-2)
- Research Credit Grant (BT-B-01-MG-18-4814, 59-082-05-2)
This publication has 46 references indexed in Scilit:
- A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's diseaseScientific Reports, 2013
- Evidence of neurodegeneration in autism spectrum disorderTranslational Neurodegeneration, 2013
- Alpha-synuclein: from secretion to dysfunction and deathCell Death & Disease, 2012
- Synapse Pathology in Psychiatric and Neurologic DiseaseCurrent Neurology and Neuroscience Reports, 2010
- Molecular mechanisms of α-synuclein neurodegenerationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophyJournal of Neural Transmission, 2006
- Serum neurotrophin concentrations in autism and mental retardation: a pilot studyBrain and Development, 2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjectsNeuroscience Letters, 2000
- The role of the alpha -synuclein gene mutation in patients with sporadic Parkinson's disease in the United KingdomJournal of Neurology, Neurosurgery & Psychiatry, 1998